ALEC Company Profile and Key Details

ALEC has shown mixed momentum, losing -0.54% over the past week and -39.8% over the past quarter, though year-to-date performance is up 17.31%. Short-term trend indicators are mixed aligned (SMA20 27.3%, SMA50 41.58%, SMA200 36.52%). The stock’s 14-day RSI is 82.29 (overbought), while the ATR of 0.16 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -24.7% below its high and over 194.25% above its low. Average 10-day trading volume of 2.08 million shares is significantly above the 3-month average of 1.16 million, indicating heightened recent market interest.

Alector, Inc. generated EPS of -$1.07 over the past year. Five-year average earnings growth is 6.31%. Wall Street analysts project EPS growth of 33.16% annually over the next five years. The latest quarter delivered EPS of -$0.21. The next quarter is forecast at -$0.25. Next year's EPS is expected at -$19.15. Analyst sentiment is bullish. Analyst rating data shows there are 0 Strong Buy ratings, 3 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $6.00 to $5.00. The high target offers 180.37% upside. The low target suggests 133.64% downside. The mean target is $5.33. This offers 149.07% upside. Alector, Inc. earnings surprise history is frequent misses against expectations. The quarter that ended August 06, 2026, missed forecasts by -5.08%. The prior quarter beat by -27.03%. Over the last six quarters, Apple has recorded several small beats. These include -6.82% in May 08, 2025.

Alector, Inc. has 111.66 million shares outstanding. The public float is 94.31 million shares, elevated short interest at 5.85% of float. This equals 6.17 million shares. The short ratio is 4.14 days. Institutional investors hold 91.01% of the float. Insiders own 9.67%. Polaris Venture Management Co. VI, L.L.C. holds 10.85 million shares, MCGUIRE TERRANCE has 10.85 million shares and Rosenthal Arnon has 2.29 million shares. Over the past six months, insider transactions show net selling. They sold 113.12 thousand shares across 6 transactions.

Dividend and splits history remains an important factor for investors monitoring long-term returns.

Alector, Inc. (NASDAQ:ALEC) closed at $2.21 USD, gaining $0.07 (3.27%) from the previous close of $2.14. The stock is currently mid-range between its 52-week high and low $1.09 and $3.40. With a market capitalization of about $245.37 million, Alector, Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~0.58). Key stats such as the average daily volume over the past year has been around 1.16 million shares, trading with heavier-than-usual volume. Headquartered in South San Francisco, CA, Alector, Inc. operates in the Healthcare sector and the Biotechnology industry. Led by CEO Arnon Rosenthal, the company employs approximately 103 people and listed since February 07, 2019. Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology.

Alector, Inc. trades at a P/E ratio of -1.99, slightly below the S&P 500 average, with a price-to-sales ratio of 17.5 and a price-to-book ratio of -24.38 indicating negative book value, which may reflect financial stress. The P/FCF stands at -1.53, also below market averages.

Our AI price prediction model suggests that Alector, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 11.21%, with price expected at $2.38 by September 25, 2026, within a range of $2.23 to $2.54 3-Month Outlook: Projected fall of -67.76%, reaching $0.69 by December 10, 2026, with a range of $0.57 to $0.78. 1-Year Outlook: Projected gain of 485.98%, with price at $12.54 by September 10, 2027, within a range of $1.17 to $20.66.

Alector, Inc. (NASDAQ:ALEC) shares are up 17.31% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Alector, Inc. trading at a premium to the broader market with a P/E of -1.99. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $17.65, suggesting 724.77% upside. Our AI forecast model points to short-term strength (11.21% over two weeks), a medium-term fall (-67.76% over three months), and a longer-term gain (485.98% over one year), with expected trading ranges indicating moderate volatility.